7780 related articles for article (PubMed ID: 11832527)
1. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
Knowler WC; Barrett-Connor E; Fowler SE; Hamman RF; Lachin JM; Walker EA; Nathan DM;
N Engl J Med; 2002 Feb; 346(6):393-403. PubMed ID: 11832527
[TBL] [Abstract][Full Text] [Related]
2. The diabetes prevention program and its global implications.
Molitch ME; Fujimoto W; Hamman RF; Knowler WC;
J Am Soc Nephrol; 2003 Jul; 14(7 Suppl 2):S103-7. PubMed ID: 12819312
[TBL] [Abstract][Full Text] [Related]
3. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.
; Knowler WC; Fowler SE; Hamman RF; Christophi CA; Hoffman HJ; Brenneman AT; Brown-Friday JO; Goldberg R; Venditti E; Nathan DM
Lancet; 2009 Nov; 374(9702):1677-86. PubMed ID: 19878986
[TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome components and their response to lifestyle and metformin interventions are associated with differences in diabetes risk in persons with impaired glucose tolerance.
Florez H; Temprosa MG; Orchard TJ; Mather KJ; Marcovina SM; Barrett-Connor E; Horton E; Saudek C; Pi-Sunyer XF; Ratner RE; Goldberg RB;
Diabetes Obes Metab; 2014 Apr; 16(4):326-33. PubMed ID: 24118860
[TBL] [Abstract][Full Text] [Related]
5. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial.
Orchard TJ; Temprosa M; Goldberg R; Haffner S; Ratner R; Marcovina S; Fowler S;
Ann Intern Med; 2005 Apr; 142(8):611-9. PubMed ID: 15838067
[TBL] [Abstract][Full Text] [Related]
6. [Steps toward the primary prevention of type II diabetes mellitus. Various epidemiological considerations].
Flórez H
Invest Clin; 1997 Mar; 38(1):39-52. PubMed ID: 9235072
[TBL] [Abstract][Full Text] [Related]
7. Impact of Lifestyle and Metformin Interventions on the Risk of Progression to Diabetes and Regression to Normal Glucose Regulation in Overweight or Obese People With Impaired Glucose Regulation.
Herman WH; Pan Q; Edelstein SL; Mather KJ; Perreault L; Barrett-Connor E; Dabelea DM; Horton E; Kahn SE; Knowler WC; Lorenzo C; Pi-Sunyer X; Venditti E; Ye W;
Diabetes Care; 2017 Dec; 40(12):1668-1677. PubMed ID: 29021207
[TBL] [Abstract][Full Text] [Related]
8. The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes.
; Crandall J; Schade D; Ma Y; Fujimoto WY; Barrett-Connor E; Fowler S; Dagogo-Jack S; Andres R
J Gerontol A Biol Sci Med Sci; 2006 Oct; 61(10):1075-81. PubMed ID: 17077202
[TBL] [Abstract][Full Text] [Related]
9. Impact of lifestyle intervention and metformin on health-related quality of life: the diabetes prevention program randomized trial.
Florez H; Pan Q; Ackermann RT; Marrero DG; Barrett-Connor E; Delahanty L; Kriska A; Saudek CD; Goldberg RB; Rubin RR;
J Gen Intern Med; 2012 Dec; 27(12):1594-601. PubMed ID: 22692637
[TBL] [Abstract][Full Text] [Related]
10. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance.
Herman WH; Hoerger TJ; Brandle M; Hicks K; Sorensen S; Zhang P; Hamman RF; Ackermann RT; Engelgau MM; Ratner RE;
Ann Intern Med; 2005 Mar; 142(5):323-32. PubMed ID: 15738451
[TBL] [Abstract][Full Text] [Related]
11. Change in adiponectin explains most of the change in HDL particles induced by lifestyle intervention but not metformin treatment in the Diabetes Prevention Program.
Goldberg RB; Temprosa M; Mele L; Orchard T; Mather K; Bray G; Horton E; Kitabchi A; Krakoff J; Marcovina S; Perreault L; White N;
Metabolism; 2016 May; 65(5):764-775. PubMed ID: 27085783
[TBL] [Abstract][Full Text] [Related]
12. HbA1c as a predictor of diabetes and as an outcome in the diabetes prevention program: a randomized clinical trial.
Diabetes Prevention Program Research Group
Diabetes Care; 2015 Jan; 38(1):51-8. PubMed ID: 25336746
[TBL] [Abstract][Full Text] [Related]
13. Alcohol consumption and diabetes risk in the Diabetes Prevention Program.
Crandall JP; Polsky S; Howard AA; Perreault L; Bray GA; Barrett-Connor E; Brown-Friday J; Whittington T; Foo S; Ma Y; Edelstein SL;
Am J Clin Nutr; 2009 Sep; 90(3):595-601. PubMed ID: 19640960
[TBL] [Abstract][Full Text] [Related]
14. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.
Tuomilehto J; Lindström J; Eriksson JG; Valle TT; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Laakso M; Louheranta A; Rastas M; Salminen V; Uusitupa M;
N Engl J Med; 2001 May; 344(18):1343-50. PubMed ID: 11333990
[TBL] [Abstract][Full Text] [Related]
15. The rationale, design, and baseline characteristics of PREVENT-DM: A community-based comparative effectiveness trial of lifestyle intervention and metformin among Latinas with prediabetes.
Perez A; Alos VA; Scanlan A; Maia CM; Davey A; Whitaker RC; Foster GD; Ackermann RT; O'Brien MJ
Contemp Clin Trials; 2015 Nov; 45(Pt B):320-327. PubMed ID: 26597415
[TBL] [Abstract][Full Text] [Related]
16. A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study.
Hoeger KM; Kochman L; Wixom N; Craig K; Miller RK; Guzick DS
Fertil Steril; 2004 Aug; 82(2):421-9. PubMed ID: 15302293
[TBL] [Abstract][Full Text] [Related]
17. A clinical trial to maintain glycemic control in youth with type 2 diabetes.
; Zeitler P; Hirst K; Pyle L; Linder B; Copeland K; Arslanian S; Cuttler L; Nathan DM; Tollefsen S; Wilfley D; Kaufman F
N Engl J Med; 2012 Jun; 366(24):2247-56. PubMed ID: 22540912
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes.
Eddy DM; Schlessinger L; Kahn R
Ann Intern Med; 2005 Aug; 143(4):251-64. PubMed ID: 16103469
[TBL] [Abstract][Full Text] [Related]
19. The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes.
The Diabetes Prevention Program Research Group
Diabetes Care; 1999 Apr; 22(4):623-34. PubMed ID: 10189543
[TBL] [Abstract][Full Text] [Related]
20. Body size and shape changes and the risk of diabetes in the diabetes prevention program.
Fujimoto WY; Jablonski KA; Bray GA; Kriska A; Barrett-Connor E; Haffner S; Hanson R; Hill JO; Hubbard V; Stamm E; Pi-Sunyer FX;
Diabetes; 2007 Jun; 56(6):1680-5. PubMed ID: 17363740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
